Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
J Mother Child ; 24(3): 32-36, 2021 Apr 30.
Article in English | MEDLINE | ID: mdl-33930262

ABSTRACT

The Mediator complex subunit 13-like is a part of the large Mediator complex. Recently, a large number of patients were diagnosed with mutations in this gene, which makes it one of the most frequent causes of syndromic intellectual disability. In this work, we report a patient with a novel de novo likely pathogenic variant c.5941C>T, p.(Gln1981*) in the MED13L gene with severe intellectual disability and facial dysmorphism. Uncommon findings like lack of speech, strabismus and self-destructive behaviour present in our patient allowed us to further define the phenotypic spectrum of mental retardation and distinctive facial features with or without cardiac defects syndrome.


Subject(s)
Abnormalities, Multiple/diagnosis , Abnormalities, Multiple/genetics , Abnormalities, Multiple/physiopathology , Haploinsufficiency , Intellectual Disability/genetics , Loss of Function Mutation , Mediator Complex/genetics , Child , Genetic Variation , Humans , Intellectual Disability/diagnosis , Intellectual Disability/physiopathology , Male , Mutation , Phenotype
2.
Transplant Proc ; 52(9): 2844-2848, 2020 Nov.
Article in English | MEDLINE | ID: mdl-32684371

ABSTRACT

Juvenile xanthogranuloma (JXG) is a rare histiocytic disorder classified as non-Langerhans cell histiocytosis; although it is usually a benign and self-limiting disease, it can be fatal in some cases, especially with systemic dissemination. We present a case report of a boy with therapy-resistant disseminated JXG who was treated with systemic chemotherapy and received 3 allogeneic hematopoietic stem cell transplantations (allo-HSCTs) from an unrelated donor. The post-transplant period was complicated by acute graft vs host disease and lymphoproliferative disease caused by Epstein-Barr virus. Currently, almost 7.5 years after the first transplantation, the boy is in complete remission with full donor chimerism and without symptoms of JXG. The presented data confirm rare observations that allo-HSCT can lead to durable remission of systemic JXG, which warrants its use in life-threatening, therapy-resistant subtypes of disease.


Subject(s)
Busulfan/analogs & derivatives , Combined Modality Therapy/methods , Hematopoietic Stem Cell Transplantation/methods , Salvage Therapy/methods , Xanthogranuloma, Juvenile/therapy , Antineoplastic Agents, Alkylating/therapeutic use , Busulfan/therapeutic use , Child, Preschool , Humans , Male , Remission Induction , Xanthogranuloma, Juvenile/complications
SELECTION OF CITATIONS
SEARCH DETAIL
...